Clinical trial Recruiting at 2 sites Interventional Ages 65 and up

Organ-sparing surgery for elderly patients with early colon cancer

Official title: Organ SPARring Surgery vs. Standard Resection for Early Stage COLon Cancer in Elderly Frail Patients

Run by Zealand University Hospital · NCT05734300 · Data updated 2026-11-12

This study is testing a new, less invasive surgery for older patients with early colon cancer to see if it can be safer and easier than traditional surgery.

More Frailty trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment48 (estimated)
SponsorZealand University Hospital
Academic / other
Locations3 sites (Copenhagen, Herlev and 2 other locations)
StatusRecruiting
StartedMay 1, 2023
Main results expectedMay 1, 2025
Study endsSeptember 1, 2027
Registry record updatedJuly 25, 2023
Trial IDNCT05734300 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are males and females aged 75 years and older with early-stage colon adenocarcinoma who are suitable for the CELS procedure.

Probably not a fit

Patients with high-risk histological features or other malignancies, as well as those unable to provide informed consent, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a new organ-preserving surgical approach called Combined Endoscopic Laparoscopic Surgery (CELS) for elderly patients diagnosed with early-stage colon cancer. The aim is to determine if this less invasive technique can reduce the risks associated with traditional resection methods, particularly for frail patients. Participants aged 75 and older with specific tumor characteristics will be recruited to assess the safety and effectiveness of CELS compared to standard resection. The study focuses on minimizing surgical trauma while ensuring effective cancer treatment.

Why it matters

Potential benefit: If successful, this approach could significantly reduce surgical risks and improve recovery outcomes for elderly patients with early colon cancer.

How similar studies have gone: While this specific approach is novel, similar minimally invasive techniques have shown promise in other studies, indicating potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male and Female participants providing written informed consent aged 75 years and older
* PS score ≥1 and /or ASA score ≥3
* Macroscopically or pathological colonic adenocarcinoma
* Clinical TNM classification T1/T2 N0 M0
* Eligible and suitable for CELS resection according to MDT
* Tumor must be located in colon, and not involving the ileac valve or taking up more than 50% of the lumen in an air-distended bowel wall

Exclusion Criteria:

* Unable to give informed consent
* Histological high-risk features in biopsy material from tumor (mucin, signet cells, de- differentiation)
* Suspected other malignancy than adenocarcinoma (e.g. neuroendocrine tumors)
* Preoperative chemo/radiotherapy
* Creation of stoma perioperative
* Non-Danish speakers

Where it's running

  • Copenhagen University Hospital - Herlev
    Copenhagen, Herlev, Denmark
    Recruiting
  • Zealand University Hospital
    Køge, Denmark
    Recruiting
  • Hospital Soenderjylland
    Aabenraa, Denmark
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.